Ethic Inc’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding RGEN
UCFA
VCM
VPM
MC
Ethic Inc's RGEN Position: Q1 2026 in Review
Ethic Inc sold out of Repligen (RGEN) in Q1 2026, closing a stake of 1,685 shares — an estimated $276K sold.
Ethic Inc first reported a position in RGEN in Q2 2021 and held it in 18 quarters. The position peaked at $651K in Q1 2025. 441 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.
- Ethic Inc reported no remaining Repligen position as of Q1 2026 after selling out during the quarter.
- Ethic Inc sold 1,685 Repligen shares in Q1 2026, an estimated $276K.
- Ethic Inc first reported a position in Repligen in Q2 2021 and held it in 18 quarters.
- Ethic Inc's Repligen position peaked at $651K in Q1 2025.
- 441 funds tracked by Wall St. Rank held Repligen as of Q1 2026.
Based on Ethic Inc's 13F filing for Q1 2026, filed 27 Apr 2026.